EYLEA
NDC 61755-005 · Regeneron Pharmaceuticals, Inc.
Generic nameaflibercept
Dosage formINJECTION, SOLUTION
RouteINTRAVITREAL
Active ingredient(s)AFLIBERCEPT
Strength40 mg/mL
Pharmacologic classVascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
Marketing categoryBLA
Packages
61755-005-01 — 1 SYRINGE, GLASS in 1 CARTON (61755-005-01) / .05 mL in 1 SYRINGE, GLASS
61755-005-02 — 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) / .05 mL in 1 VIAL, SINGLE-USE
61755-005-54 — 1 SYRINGE, GLASS in 1 CARTON (61755-005-54) / .05 mL in 1 SYRINGE, GLASS
61755-005-55 — 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-55) / .05 mL in 1 VIAL, SINGLE-USE
Billed under HCPCS
J0178 — Injection, aflibercept, 1 mg Medicare Part B payment limit (ASP + 6%): $743.61
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0024-5840 — ziv-aflibercept, 0024-5841 — ziv-aflibercept, 55513-056 — aflibercept-ayyh, 55513-065 — aflibercept-ayyh, 61755-050 — aflibercept, 61755-051 — aflibercept, 83257-035 — aflibercept-jbvf